Additionally, glucose-restricted dietary approaches facilitate p53 mutant deacetylation and breakdown; consequently, KDs either inhibit p53 mutant function or suppress gene expression throughout cancer development and advancement [117]. The gene discussed is TP53; the disease is cancer.